Chemoinformaics analysis of Delphinidin 3,5-diglucoside
| Molecular Weight | 627.528 | nRot | 7 |
| Heavy Atom Molecular Weight | 596.28 | nRig | 29 |
| Exact Molecular Weight | 627.156 | nRing | 5 |
| Solubility: LogS | -2.01 | nHRing | 3 |
| Solubility: LogP | -1.433 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 79.3946 |
| nHD | 12 | BPOL | 39.7794 |
| QED | 0.096 |
| Synth | 5.041 |
| Natural Product Likeliness | 1.597 |
| NR-PPAR-gamma | 0.831 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.97 |
| HIA | 0.978 |
| CACO-2 | -6.543 |
| MDCK | 0.000104021 |
| BBB | 0.437 |
| PPB | 0.782629 |
| VDSS | 0.801 |
| FU | 0.280944 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.009 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.066 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.001 |
| CL | 1.685 |
| T12 | 0.658 |
| hERG | 0.022 |
| Ames | 0.442 |
| ROA | 0.033 |
| SkinSen | 0.041 |
| Carcinogencity | 0.044 |
| EI | 0.005 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.851 |
| Antiviral | Yes |
| Prediction | 0.807622 |